Skip to main content

Table 4 First VTE event within 6 months from discharge (%) stratified by cancer site and chemotherapy

From: Risk of venous thromboembolism in hospitalised cancer patients in England—a cohort study

Cancer site

No. of people alive and no VTE during hospitalisation

Chemotherapy

VTE

%

No chemotherapy

VTE

%

Breast

485,009

138,776

1871

1.35

346,233

1772

0.51

Lung

278,182

71,155

2389

3.36

207,027

4047

1.95

Bowel

364,489

96,577

1853

1.92

267,912

3782

1.41

Prostate

335,231

17,687

180

1.02

317,544

2011

0.63

Non-Hodgkin lymphoma

113,989

60,495

1165

1.93

53,494

990

1.85

Malignant melanoma

82,445

4088

20

0.49

78,357

135

0.17

Bladder

217,217

32,418

291

0.90

184,799

1256

0.68

Kidney

60,755

4458

61

1.37

56,297

663

1.18

Oesophageal

79,812

22,786

1063

4.67

57,026

1316

2.31

Stomach

66,314

14,916

726

4.87

51,398

1160

2.26

Pancreatic

52,296

12,015

625

5.20

40,281

1290

3.20

Leukaemia

86,648

23,957

287

1.20

62,691

641

1.02

Uterus

68,516

7615

146

1.92

60,901

559

0.92

Ovarian

57,162

28,259

613

2.17

28,903

701

2.43

Oral

62,784

12,080

114

0.94

50,704

264

0.52

Brain

55,107

6726

135

2.01

48,381

1218

2.52

Multiple myeloma

48,944

18,175

348

1.91

30,769

685

2.23

Liver

36,485

5228

155

2.96

31,257

628

2.01

Cervix

30,596

7651

177

2.31

22,945

282

1.23

Laryngeal

22,879

2711

15

0.55

20,168

71

0.35

Testicular

22,481

9119

103

1.13

13,362

98

0.73

Bone/connective tissue

26,490

4231

78

1.84

22,259

215

0.97

Thyroid

21,368

717

3

0.42

20,651

53

0.26

Mesothelioma

17,350

4908

120

2.44

12,442

229

1.84

Other site

87,853

36,920

476

1.30

50,933

714

1.40

Unknown

163,390

25,095

1128

4.49

138,295

2894

2.09

Total

2,943,792

668,763

14,142

2.11

2,275,029

27,674

1.22